Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend up · inside the Ichimoku cloud · RSI 100 (overbought) · MACD below its signal · at its 52-week high
| 0.000100 | Price now | |
| 0.000100 | R3 (classic) | −0.00% |
| 0.000100 | R2 (classic) | −0.00% |
| 0.000100 | R1 (classic) | −0.00% |
| 0.000100 | Pivot | −0.00% |
| 0.000100 | S1 (classic) | −0.00% |
| 0.000100 | S2 (classic) | −0.00% |
| 0.000100 | S3 (classic) | −0.00% |
| 0.000100 | Previous day high | −0.00% |
| 0.000100 | Previous day low | −0.00% |
| 0.000100 | Previous week high | −0.00% |
| 0.000100 | Previous week low | −0.00% |
| 0.000100 | Previous month high | −0.00% |
| 0.000100 | Previous month low | −0.00% |
| 0.000100 | 52-week high | −0.00% |
| 0.000010 | 52-week low | −90.00% |
None of the 29 investors followed here reported a position in HESG in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a HESG trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for HESG.
TimeframesUp on the weekly and monthly, mixed on the daily.
bouncing over the 21 EMA
over a rising 21 EMA, 21 over 50
over a rising 21 EMA, 21 over 50
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | 900.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | +900.0% | ||
| 2025 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2024 | 0.0 | -90.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −90.0% |
| 2023 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2022 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2021 | 200.0 | 100.0 | -33.3 | 50.0 | -33.3 | 25.0 | -40.0 | -33.3 | -50.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2020 | -50.0 | 100.0 | 0.0 | -50.0 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2019 | 0.0 | 0.0 | 0.0 | 0.0 | -90.0 | 900.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −0.0% |
| 2018 | 0.0 | 0.0 | 0.0 | 0.0 | -50.0 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2017 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2016 | 0.0 | 0.0 | 900.0 | -90.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −0.0% |
| 2015 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -90.0 | 900.0 | 0.0 | 0.0 | 0.0 | −0.0% |
| 2014 | 200.0 | 0.0 | -33.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -50.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2013 | -50.0 | 100.0 | 0.0 | -50.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −50.0% |
| 2012 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | +100.0% |
| 2011 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2010 | -60.0 | 0.0 | 0.0 | -50.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | -50.0 | 0.0 | −80.0% |
| 2009 | 1650.0 | -94.3 | -50.0 | 0.0 | 0.0 | 100.0 | 0.0 | -50.0 | 0.0 | 100.0 | 400.0 | -50.0 | +150.0% |
| 2008 | -14.3 | 33.3 | 75.0 | -42.9 | 25.0 | 0.0 | -30.0 | 14.3 | -37.5 | 40.0 | -57.1 | -33.3 | −71.4% |
| 2007 | -28.6 | -20.0 | -15.0 | -85.3 | 20.0 | 0.0 | -33.3 | 0.0 | -65.0 | 71.4 | 0.0 | -41.7 | −98.0% |
No analyst coverage for this instrument.
Health Sciences Group, Inc., through its subsidiaries, provides various products used in nutritional supplements and functional foods and beverages in the United States. It primarily offers Shugr, a zero-calorie sugar substitute that tastes and bakes like cane sugar; and Sequesterol Advance Cardio Formula, a proprietary blend of clinically studied ingredients for the maintenance of cardiovascular health and a free-flowing circulatory system. The company also offers Aplevia, an antioxidant derived from apple peels; and Edible Sponges, an open-cell hydrocolloid product. It sells its products primarily through mass market retailers, such as mass merchandisers, drug stores, supermarkets, and discount stores, as well as through healthcare professionals and practitioners, and other media. Health Sciences Group was founded in 1996 as Centurion Properties Development Corporation and changed its name to iGoHealthy.com in 2000. It changed its name to Health Sciences Group, Inc. in 2001. The company is based in Newport Beach, California.
No recent headlines.